Who We Are

We are an international team of dedicated researchers, experienced business partners, and visionary investors united by a common goal: to revolutionize cancer therapy. Our diverse expertise spans virology, oncology, immunology, and business strategy, allowing us to approach cancer treatment from multiple angles.

Our Focus

Virofend Therapeutics is committed to creating novel, targeted virotherapies that can effectively fight cancer while minimizing side effects. We leverage the latest advancements in genetic engineering and immunology to develop viruses that selectively target and destroy cancer cells, while also stimulating the body's immune system to join the fight.

Our Goal

Our mission is to provide innovative therapeutic solutions to cancer patients, improving treatment outcomes and quality of life. We strive to transform the landscape of cancer therapy by offering alternatives to traditional treatments and complementing existing therapies.

Join Us in the Fight Against Cancer

Whether you're a patient, healthcare professional, researcher, or potential partner, we invite you to explore how Virofend Therapeutics is shaping the future of cancer treatment. Together, we can make a significant impact in the lives of those affected by cancer. Discover the power of virotherapy with Virofend Therapeutics – where science meets hope in the battle against cancer.